Bioxytran, Inc.
BIXT
$0.109
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -168.78% | -25.55% | 39.38% | -18.06% | 45.58% |
| Total Depreciation and Amortization | -34.48% | 93.33% | 0.00% | -25.00% | -47.37% |
| Total Amortization of Deferred Charges | -- | 2,391.20% | -16.67% | -- | -- |
| Total Other Non-Cash Items | 589.01% | -425.86% | -21.50% | -85.24% | 309.44% |
| Change in Net Operating Assets | 282.95% | -73.88% | -30.75% | 31,925.00% | -100.14% |
| Cash from Operations | -479.37% | 46.03% | 155.41% | 50.27% | -18.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -32.97% | -727.27% | 81.67% | 9.09% |
| Cash from Investing | 100.00% | -32.97% | -727.27% | 81.67% | 9.09% |
| Total Debt Issued | 370.73% | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 370.73% | -- | -100.00% | -40.70% | 121.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.29% | -239.15% | 505.71% | 121.74% | 70.30% |